Miner Company
Oruka's experimental drug helps clear psoriasis in mid-stage study
Oruka Therapeutics said on Monday that interim results showed its experimental drug helped clear psoriasis within 16 weeks, meeting the main goal of a mid-stage study and sending shares up 43.4% in premarket trading.
Oruka Therapeutics said on Monday that interim results showed its experimental drug helped clear psoriasis within 16 weeks, meeting the main goal of a mid-stage study and sending shares up 43.4% in premarket trading.